Evidence map›Paper›PMID 21384396›Full record

ArticleLasers in surgery and medicine2011

A clinical instrument for combined raman spectroscopy-optical coherence tomography of skin cancers.

Chetan A Patil, Harish Kirshnamoorthi, Darrel L Ellis, Ton G van Leeuwen, Anita Mahadevan-Jansen

Abstract readEvaluation Study
In one paragraph

Article in Lasers in surgery and medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Longitudinal Morphomolecular Monitoring of Head and Neck Carcinogenesis.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Raman Spectroscopy: Guiding Light for the Extracellular Matrix.Frontiers in bioengineering and biotechnology · 2019
    Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Chetan A PatilDepartment of Biomedical Engineering, Vanderbilt University, Nashville, Tennessee 137235, USA. c.patil@vanderbilt.edu
Harish Kirshnamoorthi
Darrel L Ellis
Ton G van Leeuwen
Anita Mahadevan-Jansen

Funding

UV, APOPTOSIS, PROTEIN PHOSPHATASE AND SKIN DISEASEP30AR041943 · NIAMS · VANDERBILT UNIVERSITY · PI MCCAWLEY, LISA JOY · 1994 to 2008
$5.3M
Development of a handheld probe for confocal microscopy and Raman spectroscopy*R01CA114471 · NCI · VANDERBILT UNIVERSITY · PI MAHADEVAN-JANSEN, ANITA · 2006 to 2010
$1.4M
Combined raman spectroscopy-optical tomagraphy for complete diagnosis of skin canR21CA133477 · NCI · VANDERBILT UNIVERSITY · PI MAHADEVAN-JANSEN, ANITA · 2008 to 2009
$352k
NCI NIH HHS R01 CA114471NCI NIH HHS R21 CA133477NCI NIH HHS R21 CA133477 01/02NIAMS NIH HHS P30 AR041943
6 · The paper itself

Abstract

BACKGROUND AND

objectiveThe current standard for diagnosis of skin cancers is visual inspection followed by biopsy and histopathology. This process can be invasive, subjective, time consuming, and costly. Optical techniques, including Optical Coherence Tomography (OCT) and Raman Spectroscopy (RS), have been developed to perform non-invasive characterization of skin lesions based on either morphological or biochemical features of disease. The objective of this work is to report a clinical instrument capable of both morphological and biochemical characterization of skin cancers with RS-OCT. MATERIALS AND

methodsThe portable instrument utilizes independent 785 nm RS and 1,310 nm OCT system backbones. The two modalities are integrated in a 4″ (H) × 5″(W) × 8″(L) clinical probe. The probe enables sequential acquisition of co-registered OCT and RS data sets. The axial response of the RS collection in the skin was estimated using scattering phantoms. In addition, RS-OCT data from patients with cancerous and non-cancerous lesions are reported.

resultsThe RS-OCT instrument is capable of screening areas as large as 15 mm (transverse) by 2.4 mm (in depth) at up to 8 frames/second with OCT, and identifying locations to perform RS. RS signal is collected from a 44 µm transverse spot through a depth of approximately 530 µm. RS-OCT data sets from a superficial scar and a nodular BCC are reported to demonstrate the clinical potential of the instrument.

conclusionThe RS-OCT instrument reported here is capable of morphological and biochemical characterization of cancerous skin lesions in a clinical setting. OCT can visualize microstructural irregularities and perform an initial morphological analysis of the lesion. The images can be used to guide acquisition of biochemically specific Raman spectra. The two data sets can then be evaluated with respect to one another to take advantage of the mutually complimentary nature of RS and OCT.

Indexed as

AgedBasal Cell CarcinomaHumansMaleMiddle AgedSkin NeoplasmsSpectrum Analysis, RamanTomography, Optical Coherence

Identifiers

PMID21384396
PMCPMC4014065

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.